Ticker: Brian Williams Teams With Netflix for New Podcast Series
Christine Romans to get a two-hour show on NBC News Now.Read More
Christine Romans to get a two-hour show on NBC News Now.Read More
Artemis II and Iran coverage led to viewership for cable.Read More

The Eindhoven neurotechnology company is using the proceeds to fund its Empower BP pivotal trial, which tests whether its implantable ARC-IM® system can treat blood pressure instability after spinal cord injury, while expanding commercial rollout of its already-cleared ARC-EX® external therapy system. Cash runway now extends to Q1 2028. ONWARD Medical has raised €40.6 million […]
This story continues at The Next WebRead More

Post Telecom (with CleverCloud and OVHcloud), StackIT, Scaleway, and Proximus (with S3NS, a Thales – Google Cloud joint venture, plus Clarence and Mistral) have won the European Commission’s six-year sovereign cloud framework contract. The Proximus consortium’s inclusion signals that non-European technology can qualify as ‘sovereign’ under the Commission’s framework if operated within a sufficiently strict […]
This story continues at The Next WebRead More

The Cologne-based translation company best known for its text tools has unveiled a full voice product suite covering meetings, conversations, group settings, and an API for enterprise integration. A live demo in Seoul showed one-to-two sentence delays, and DeepL’s CPO acknowledged word order differences between languages remain a fundamental challenge. DeepL, the Cologne-based language AI […]
This story continues at The Next WebRead More
What do your supporters tell their friends?
That’s the unseen force behind every successful brand, movement or idea.
Most people don’t care about you. They’re not listening to you, not wondering what you’re up to, and certainly not taking the time to seek you out. All you have is a small circle, your supporters.
And yet, we spend most of our time treating people like customers, not supporters. We try to turn strangers into people who do business with us, taking the friends and supporters we’ve earned for granted.
Instead, with planning and focus, you can create the conditions where your efforts strike a chord. When your customers become fans, they spread the word. When your story is true, relevant, focused, and sticky, new fans arrive. Not because it matters to you, but because it matters to them.
The second circle is out of your direct control, and it’s tempting to ignore it. But the second circle unlocks the change you seek to make.

AlixLabs, the Lund-based semiconductor process startup developing Atomic Pitch Splitting (APS™), has completed its €15M Series A with a strategic top-up from Finnish investor Stephen Industries. The company is targeting beta testing with chipmakers in 2026 and manufacturing deployment by 2027. AlixLabs, a deep-tech semiconductor startup based in Lund, Sweden, has closed its €15 million […]
This story continues at The Next WebRead More

The Swedish telecoms equipment maker narrowly missed profit forecasts, with adjusted EBITA falling 20% year-on-year to SEK 5.6 billion. North America, which drove a 20%+ surge in Q1 2025, declined sharply as prior-year pull-forward investment unwinds. CEO Ekholm blames rising semiconductor input costs, partly driven by AI demand. Ericsson reported a sharp fall in profitability […]
This story continues at The Next WebRead More

Named after the crystallographer who helped reveal the structure of DNA, GPT-Rosalind is OpenAI’s first domain-specific model series, fine-tuned for biochemistry, genomics, and protein engineering. Access is restricted to a trusted-access programme for vetted enterprise customers including Amgen, Moderna, and Thermo Fisher Scientific. OpenAI has launched GPT-Rosalind, a frontier reasoning model built specifically for life […]
This story continues at The Next WebRead More

The European Investment Bank is lending €20 million to BioLamina, the Swedish biotech that supplies the laminin-based cell culture matrices used by stem cell therapy developers worldwide. The funding will support expanded production of laminin technologies and animal-free drug safety testing methods. BioLamina, the Stockholm-based biotechnology company that produces the protein scaffolding used to grow […]
This story continues at The Next WebRead More